Biotech
-
16.0K6Leronlimab Trial Results All But Certain Pointing to Approval For CytoDyn
CytoDyn Inc. (OTMKTS: CYDY) announced discussions with 3 regulatory agencies after an unblinding of the data on February 22, 2021, and the...
-
6.7KEight Mushroom Penny Stocks Causing Portfolios to Go Psychedelic
Welcome to the brave new world of psychedelic wellness and investors are taking notice. Mushroom penny stocks have witnessed the cannabis craze...
-
19.1K1Reddit Rebellion Targeting The Short Mafia Next
The BANG stocks (Blackberry (NYSE: BB), AMC Entertainment (NYSE: AMC), Nokia Inc. (NYSE: NOK), GameStop Corp (NYSE: GME) are experiencing wild pric...
-
13.9KRISE of the COVID-19 Therapeutics CytoDyn (OTCMKTS: CYDY) & Humanigen (NASDAQ:HGEN)
Enrollment Key Metric in Therapeutic Race Philippines EUA Relevant to CytoDyn, not Humanigen Highly Credentialed Humanigen Team Possibility of NAS...
-
5.4KPsyched Wellness: The Next Magic Mushroom Play
Psychedelics and magic mushrooms are all the rage these days. This is the new hot sector for investors to be in. We...
-
5.3KRVVTF and RSCF Penny Stocks on the Move
RVVTF and RSCF are two penny stocks on the move. We said back on November 2nd to buy the dip in RVVTF when the...
-
13.2K1CytoDyn (OTCMKTS: CYDY) Subtly Signals Pivot Into Philippines and Vaccine Market
On Sunday Night CytoDyn Inc. (OTCMKTS:CYDY) quietly placed a link in their developing news section to a 2016 medical journal article that...
-
19.6K1BioClonetics ENZC Merger Is A Really Big Deal
Our job at Insider Financial is to have our fingers on the pulse of what’s happening in the penny stock world for...
-
6.1KWill Biogen Now Buy Anavex Life Sciences?
Last week’s negative FDA advisory committee vote may be the final nail in the coffin in the up-and-down registration path of Biogen...
-
6.1K1CytoDyn (OTCMKTS: CYDY) Accelerates Recruitment to 250 Patients in Pivotal COVID-19 Trial
CytoDyn Inc. (OTCMKTS:CYDY) on a conference call yesterday revealed that approximately 250 patients have been recruited in their CD12 severe to cri...
